Skip to main content
. 2025 Aug 27;16(4):1597–1609. doi: 10.21037/jgo-2024-1015

Figure 4.

Figure 4

Hepatic carcinoma-related average direct medical cost for eligible patients by different cost categories. The observation periods of 20 patients spanned over 01 March 2021, thus these patients were not included in either before or after 01 March 2021 subgroup. The costs within each bar may not sum up to the total cost of each bar in red due to rounding issue. CNY, Chinese Yuan.